• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Biogen, Samsung Bioepis launch ranibizumab-nuna in US

cafead

Administrator
Staff member
  • cafead   Jun 03, 2022 at 09:12: AM
via The companies are marketing the first FDA-approved ophthalmology biosimilar as a treatment option for patients with retinal disorders.

article source
 

<